TSX Delisting Review - Chemokine Therapeutics Corp.

TORONTO -- DELISTING REVIEW - Chemokine Therapeutics Corp. (the "Company") - TSX is reviewing the common shares of the Company (Symbol: CTI) with respect to meeting the requirements for continued listing. The common shares of the Company are suspended from trading immediately and the Company is being reviewed on an expedited basis.

About TMX Group (TSX-X) -----------------------

TMX Group's key subsidiaries operate cash and derivative markets for multiple asset classes including equities, fixed income and energy. Toronto Stock Exchange, TSX Venture Exchange, Montreal Exchange, Natural Gas Exchange, Boston Options Exchange (BOX), Shorcan, Equicom and other TMX Group companies provide trading markets, clearing facilities, data products and other services to the global financial community. TMX Group is headquartered in Toronto with offices in Montreal, Calgary and Vancouver. For more information about TMX Group, visit our website at www.tsx.com.

SOURCE: TSX Reviews and Suspensions

SOURCE: Toronto Stock Exchange

SOURCE: TSX Corporate Announcements


Corporate Communications, TMX Group Inc., Toll Free 1-888-873-8392, info@tsx.com

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here